Artemisinin combination therapy trials need longer follow-up to detect late treatment failures for Plasmodium falciparum malaria
28 Mar 2022
WWARN researchers have been assessing the recommended minimum follow-up period in capturing polymerase chain reaction (PCR)-confirmed recrudescence following treatment with fixed-dose artemisinin combination therapies (ACTs) for patients with uncomplicated Plasmodium falciparum malaria.
